Enantioselective HPLC‐UV method for determination of eslicarbazepine acetate (BIA 2‐093) and its metabolites in human plasma
- 26 June 2007
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 21 (11) , 1127-1134
Abstract
Eslicarbazepine acetate (BIA 2‐093) is a novel central nervous system drug undergoing clinical phase III trials for epilepsy and phase II trials for bipolar disorder. A simple and reliable chiral reversed‐phase HPLC‐UV method was developed and validated for the simultaneous determination of eslicarbazepine acetate, oxcarbazepine, S‐licarbazepine and R‐licarbazepine in human plasma. The analytes and internal standard were extracted from plasma by a solid‐phase extraction using Waters Oasis® HLB cartridges. Chromatographic separation was achieved by isocratic elution with water–methanol (88:12, v/v), at a flow rate of 0.7 mL/min, on a LichroCART 250‐4 ChiraDex (β‐cyclodextrin, 5 µm) column at 30°C. All compounds were detected at 225 nm. Calibration curves were linear over the range 0.4–8 µg/mL for eslicarbazepine acetate and oxcarbazepine, and 0.4–80 µg/mL for each licarbazepine enantiomer. The overall intra‐ and interday precision and accuracy did not exceed 15%. Mean relative recoveries varied from 94.00 to 102.23% and the limit of quantification of the assay was 0.4 µg/mL for all compounds. This method seems to be a useful tool for clinical research and therapeutic drug monitoring of eslicarbazepine acetate and its metabolites S‐licarbazepine, R‐licarbazepine and oxcarbazepine. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 43 references indexed in Scilit:
- A high‐performance liquid chromatographic method for determination of mitragynine in serum and its application to a pharmacokinetic study in ratsBiomedical Chromatography, 2007
- Clinical Pharmacokinetics of OxcarbazepineClinical Pharmacokinetics, 2003
- Bioanalytical method validation and its implications for forensic and clinical toxicology - A reviewAccreditation and Quality Assurance, 2002
- Linear regression for calibration lines revisited: weighting schemes for bioanalytical methodsJournal of Chromatography B, 2002
- Simultaneous determination of four antiepileptic drugs in serum by high‐performance liquid chromatographyBiomedical Chromatography, 2001
- Treating Epilepsy in the ElderlyDrug Safety, 2001
- Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?Clinical Pharmacokinetics, 2000
- Oxcarbazepine: current status and clinical applicationsExpert Opinion on Investigational Drugs, 1999
- Advances in the Medical Treatment of EpilepsyAnnual Review of Medicine, 1998
- Stereoselective Bioanalysis of Oxcarbazepine and the Enantiomers of Its Metabolites by High-Performance Liquid ChromatcgraphyJournal of Liquid Chromatography, 1995